Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.


TSX:MBX - Post by User

Bullboard Posts
Post by longondmxon Jan 01, 2016 11:43am
154 Views
Post# 24423675

News release comments

News release comments

Mr. Embro-Pantalony said, "While the complexity of the LumiSort™ partnership discussions, combined with the number of potential parties involved, has resulted in a lengthier negotiation process than we originally anticipated, we are moving closer to a deal that we believe will provide the most beneficial terms for Microbix while unlocking maximum value for our shareholders. We will, of course, provide updates as developments materialize."

Good news.  As soon as something is signed we will see a pop in share price.  Depending on who joins and structure of deal the pop could be very big.  Either way it wiIl pop once signed. 




Who scored this deal?   Ten percent return for a one year facility to a company that is at near zero percent chance of failing.  I would want in on that. --> ",The company has arranged a short-term credit facility of $200,000 with two insiders of the corporation that can be drawn upon to enhance its working capital. The facility is unsecured and carries an interest rate of 10% and a maximum term of one year. The facility is non-dilutive involving no securities of the Company."

also anyone  understand how they can earn $400,000 from a prospective distributor of lumisort?  What did the prospective buyer get for that money?


despite the drop is share price this year from high $ 0.80s, that can easily be made up from one good announcement.  I am not discouraged.   I ask myself if I would buy in at current levels and the answer is a definite yes.  Hard to find reasons why the price will go down from here. 

Bullboard Posts